Preventing Bed-rest Induced Muscle Loss in the Elderly
Exercise 'Prehabilitation': A Novel Intervention to Protect Against Disuse-induced Muscle Atrophy and Sarcopenia in the Old
1 other identifier
interventional
20
1 country
1
Brief Summary
Episodes of inactivity due to hospitalisation, as short as 5 days, are associated with rapid muscle and strength loss in the elderly. The observed muscle loss with inactivity is likely due to muscle anabolic resistance and increased breakdown rates of muscle tissue. This is of great concern as the average hospital stay in the elderly is 5-6 days. Moreover, minor illnesses not requiring hospitalisation generally require short-term periods of inactive home-based recovery. The accumulation of repeated disuse events in older individuals manifests in a chronic muscle anabolic resistance (i.e. the inability of muscle to respond to anabolic stimuli such as exercise and nutrition) that may underpin the slow but devastating process of age-related muscle loss. It is our belief that strategies to promote muscle health in ageing and reduce healthcare expenditure, should focus on alleviating muscle deterioration and anabolic resistance during short-term disuse. In this regard, we propose that resistance exercise (i.e. weight lifting) performed prior to a disuse event (termed 'prehabilitation') may be sufficient to offset muscle loss in older individuals. Thus, we suggest the potent effect of resistance exercise in older muscles may prevent muscle loss during short-term disuse.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 1, 2020
CompletedFirst Posted
Study publicly available on registry
June 9, 2020
CompletedJune 9, 2020
January 1, 2020
2.1 years
June 1, 2020
June 4, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Integrated myofibrillar protein synthesis rates
Myofibrillar protein synthesis rates will be measured during the prehabilitation and bed rest period in both the exercising and resting leg.
2 years
Muscle mass via MRI
Muscle volume in the quadriceps will be assessed before and after bed rest using magnetic resonance imaging techniques
2 years
Secondary Outcomes (13)
Muscle fibre properties
2 years
Physical activity levels
2 years
Step-count
2 years
Plasma biomarkers of metabolic health
2 years
Serum insulin
2 years
- +8 more secondary outcomes
Study Arms (2)
Single Exercise
EXPERIMENTALSubjects allocated to this group will perform a single bout of one-legged resistance exercise. This bout will take place 1 day prior to the start of the bed rest. The resistance exercise will consist of 8 sets of leg extensions and 8 sets of leg curls. The non-exercising leg will serve as an internal control. The dominant leg will perform the exercise.
Multi Exercise
EXPERIMENTALSubjects allocated to this group will perform 4 bouts of one-legged resistance exercise. These bouts will take place on alternate days the week leading up to the bed rest. Each resistance exercise bout will consist of 8 sets of leg extensions and 8 sets of leg curls. The non-exercising leg will serve as an internal control. The dominant leg will perform the exercise.
Interventions
Eligibility Criteria
You may qualify if:
- Males aged between 65-80 years
- No history of structured resistance training within 10 years prior to study participation.
- Generally good health as indicated by a thorough health questionnaire.
- A score of ≥9 points on the Short Physical Performance Battery to assess lower extremity function.
- Body Mass Index \<30kg/m2
You may not qualify if:
- Coagulation disorders
- Myocardial infarction
- Artery/vein disease
- Hormone replacement therapy
- Other chronic/systemic illnesses (i.e. renal failure, chronic obstructive pulmonary disease, cancer).
- Undergone 2 or more muscle biopsies from each leg previously.
- Received a stable isotope infusion in the last 3 years prior to study enrollment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Birminghamlead
- Biotechnology and Biological Sciences Research Councilcollaborator
- University of Nottinghamcollaborator
Study Sites (1)
University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences
Edgbaston, West Midlands, B15 2TT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 1, 2020
First Posted
June 9, 2020
Study Start
September 1, 2017
Primary Completion
October 1, 2019
Study Completion
January 1, 2020
Last Updated
June 9, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share